Magdalena Szmit-Zaborowska

Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Role of Troponins in CardioOncology.

Role of Troponins in CardioOncology.

Journal: Current treatment options in oncology

Published: March 01, 2026

Venous Thromboembolism Management and Anticoagulation Opportunities in Cancer Patients.

Venous Thromboembolism Management and Anticoagulation Opportunities in Cancer Patients.

Journal: European cardiology

Published: July 08, 2025

Anticoagulant therapy in patients with cancer and thrombocytopenia.

Anticoagulant therapy in patients with cancer and thrombocytopenia.

Journal: Journal of thrombosis and thrombolysis

Published: May 03, 2025

The Detailed Analysis of Polish Patients with Non-Small Cell Lung Cancer Through Insights from Molecular Testing (POL-MOL Study).

The Detailed Analysis of Polish Patients with Non-Small Cell Lung Cancer Through Insights from Molecular Testing (POL-MOL Study).

Journal: International journal of molecular sciences

Published: September 14, 2024

Venous thromboembolism is associated with increased all-cause mortality in ALK-positive non-small cell lung cancer.

Venous thromboembolism is associated with increased all-cause mortality in ALK-positive non-small cell lung cancer.

Journal: Cardio-oncology (London, England)

Published: March 13, 2024

The combination of osimertinib and savolitinib as molecular inhibition of EGFR and MET receptors may be selected to provide maximum effectiveness and acceptable toxicity.

The combination of osimertinib and savolitinib as molecular inhibition of EGFR and MET receptors may be selected to provide maximum effectiveness and acceptable toxicity.

Journal: Translational lung cancer research

Published: March 01, 2024

Nivolumab or Atezolizumab in the Second-Line Treatment of Advanced Non-Small Cell Lung Cancer? A Prognostic Index Based on Data from Daily Practice.

Nivolumab or Atezolizumab in the Second-Line Treatment of Advanced Non-Small Cell Lung Cancer? A Prognostic Index Based on Data from Daily Practice.

Journal: Journal of clinical medicine

Published: February 13, 2023

Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy.

Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy.

Journal: Cancers

Published: January 23, 2023

Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer.

Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer.

Journal: Current oncology (Toronto, Ont.)

Published: December 29, 2022

Elderly Patients with Locally Advanced and Unresectable Non-Small-Cell Lung Cancer May Benefit from Sequential Chemoradiotherapy.

Elderly Patients with Locally Advanced and Unresectable Non-Small-Cell Lung Cancer May Benefit from Sequential Chemoradiotherapy.

Journal: Cancers

Published: August 04, 2021

A case of adenoid cystic carcinoma of trachea: treatment complications and radiotherapy role.

A case of adenoid cystic carcinoma of trachea: treatment complications and radiotherapy role.

Journal: Journal of contemporary brachytherapy

Published: December 13, 2020

Cardiovascular Complications of Systemic Therapy in Non-Small-Cell Lung Cancer.

Cardiovascular Complications of Systemic Therapy in Non-Small-Cell Lung Cancer.

Journal: Journal of clinical medicine

Published: March 03, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026